期刊
DRUG METABOLISM REVIEWS
卷 42, 期 1, 页码 24-44出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/03602530903210682
关键词
-
资金
- Canadian Institutes of Health Research (CIHR) [MOP-42392, MOP-84223]
- The Natural Sciences and Engineering Research Council of Canada (NSERC)
- The Canada Research Chair Program
The human uridine diphospho (UDP)-glucuronosyltransferase (UGT) superfamily comprises enzymes responsible for a major biotransformation phase II pathway: the glucuronidation process. The UGT enzymes are located in the endoplasmic reticulum of almost all tissues, where they catalyze the inactivation of several endogenous and exogenous molecules, including bilirubin, sex steroids, numerous prescribed drugs, and environmental toxins. This metabolic pathway is particularly variable. The influence of inheritable polymorphisms in human UGT-encoding genes has been extensively documented and was shown to be responsible for a fraction of the observed phenotypic variability. Other key genomic processes are likely underlying this diversity; these include copy-number variations, epigenetic factors, and newly discovered splicing mechanisms. This review will discuss novel molecular aspects that may be determinant to UGT phenotypes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据